88 related articles for article (PubMed ID: 1457190)
61. [Correction of immune response using purified staphylococcal toxoid and likopid in the secondary immunodeficiency induced by Coxsackie virus B3].
Semenova IB; Vasil'eva IG; Akatov AK
Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):42-5. PubMed ID: 11871300
[TBL] [Abstract][Full Text] [Related]
62. Relative adjuvant efficacy of Al(OH)3 and saponin is related to the immunogenicity of the antigen.
Bomford R
Int Arch Allergy Appl Immunol; 1984; 75(3):280-1. PubMed ID: 6207115
[No Abstract] [Full Text] [Related]
63. Strategies for Using Muramyl Peptides - Modulators of Innate Immunity of Bacterial Origin - in Medicine.
Guryanova SV; Khaitov RM
Front Immunol; 2021; 12():607178. PubMed ID: 33959120
[TBL] [Abstract][Full Text] [Related]
64. Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses.
Poecheim J; Barnier-Quer C; Collin N; Borchard G
Vaccines (Basel); 2016 Sep; 4(3):. PubMed ID: 27626449
[TBL] [Abstract][Full Text] [Related]
65. Adjuvant Immune Enhancement of Subunit Vaccine Encoding pSCPI of Streptococcus iniae in Channel Catfish (Ictalurus punctatus).
Jiang J; Zheng Z; Wang K; Wang J; He Y; Wang E; Chen D; Ouyang P; Geng Y; Huang X
Int J Mol Sci; 2015 Nov; 16(12):28001-13. PubMed ID: 26602918
[TBL] [Abstract][Full Text] [Related]
66. SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.
Sharma RK; Yolcu ES; Shirwan H
Expert Rev Vaccines; 2014 Mar; 13(3):387-98. PubMed ID: 24521311
[TBL] [Abstract][Full Text] [Related]
67. Vaccine delivery using nanoparticles.
Gregory AE; Titball R; Williamson D
Front Cell Infect Microbiol; 2013; 3():13. PubMed ID: 23532930
[TBL] [Abstract][Full Text] [Related]
68. Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cruzi antigen.
Tadokoro CE; Macedo MS; Abrahamsohn IA
Immunology; 1996 Nov; 89(3):368-74. PubMed ID: 8958049
[TBL] [Abstract][Full Text] [Related]
69. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.
Andersen P
Infect Immun; 1994 Jun; 62(6):2536-44. PubMed ID: 7910595
[TBL] [Abstract][Full Text] [Related]
70. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
[TBL] [Abstract][Full Text] [Related]
71. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms.
Springall DR; Riveros-Moreno V; Buttery L; Suburo A; Bishop AE; Merrett M; Moncada S; Polak JM
Histochemistry; 1992 Nov; 98(4):259-66. PubMed ID: 1281146
[TBL] [Abstract][Full Text] [Related]
72. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
Beck Z; Matyas GR; Jalah R; Rao M; Polonis VR; Alving CR
Vaccine; 2015 Oct; 33(42):5578-5587. PubMed ID: 26372857
[TBL] [Abstract][Full Text] [Related]
73. Squalene and squalane emulsions as adjuvants.
Allison AC
Methods; 1999 Sep; 19(1):87-93. PubMed ID: 10525443
[TBL] [Abstract][Full Text] [Related]
74. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.
Allison AC; Byars NE
J Immunol Methods; 1986 Dec; 95(2):157-68. PubMed ID: 3540125
[TBL] [Abstract][Full Text] [Related]
75. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants.
Bomford R; Stapleton M; Winsor S; McKnight A; Andronova T
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1765-71. PubMed ID: 1457190
[TBL] [Abstract][Full Text] [Related]
76. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
[TBL] [Abstract][Full Text] [Related]
77. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
McCormick AL; Thomas MS; Heath AW
J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
